Neumi just told its distributors that selling company products on Amazon, eBay, and Walmart violates federal law. It doesn't.
The company fired off a company-wide email on September 27th claiming that moving Neumi products through third-party platforms breaches FTC regulations. The reasoning Neumi offered was vague: the Federal Trade Commission requires that health and wellness claims be accurate, substantiated, and not misleading. Fair enough. But that has nothing to do with which websites sell the products.
What's actually happening is transparent. Neumi operates its own Amazon store and doesn't want distributors undercutting prices on the same platform. The company is disguising an internal sales restriction as a federal compliance requirement.
Neumi's email spells it out: "When sold through unauthorized platforms, Neumi cannot guarantee product quality, authenticity, or proper representation." Translation: Neumi wants to control who sells its products and at what price. The company then admits it created an Amazon store specifically "to keep unauthorized sellers from being able to undercut prices and to control those who are not authorized to use our trademarks."
Here's the problem with Neumi's FTC argument: it's false. Selling a company's products on Amazon, eBay, or Walmart is not an FTC violation. The FTC doesn't prohibit ecommerce platforms. In fact, Neumi itself sells on Amazon. If the company's own conduct violated federal regulations, the FTC would need to explain how Neumi corporate gets a pass while distributors don't.
This type of enforcement action doesn't exist. Since 2009, there's been no recorded FTC case against MLM distributors solely for selling products on ecommerce sites. The agency has gone after MLM companies for recruitment schemes, false income claims, and pyramid structure—not for marketplace sales.
Neumi's quality control argument also falls apart. If counterfeit Neumi products appear online, sellers of those counterfeits would face liability, not authorized distributors moving legitimate inventory. Manufacturers occupy the next link in that chain. Distributors selling real Neumi products through third-party sites have no responsibility for counterfeits they didn't create or sell.
What Neumi is doing amounts to misrepresenting company policy as law. The restriction itself may be enforceable as a contractual matter between Neumi and its distributors. But claiming the FTC forbids third-party sales crosses a line. It's designed to intimidate distributors into compliance through fear of federal violations that don't exist.
eBay and Walmart lack the brand registry protections Amazon offers, which explains why Neumi specifically mentioned those sites. The company can't remove unauthorized sellers from eBay and Walmart as easily, so it's threatening FTC violations instead. That's not compliance. That's coercion disguised as regulation.
🤖 Quick Answer
Does selling Neumi products on third-party marketplaces violate FTC regulations?
No. Neumi's claim that selling products on Amazon, eBay, and Walmart breaches FTC regulations lacks legal foundation. FTC requirements concerning health and wellness claims pertain to accuracy and substantiation of marketing statements, not to the selection of sales channels or distribution platforms.
What is Neumi's actual motivation for restricting third-party sales?
Neumi operates its own Amazon store and seeks to prevent price competition from distributors on the same platform. The company reframed this commercial restriction as a federal compliance requirement to justify the sales limitation internally.
What did Neumi communicate to its distributors?
Neumi issued a company-wide email on September 27th instructing distributors that selling products through third-party platforms such as Amazon, eBay, and Walmart constitutes a violation of
🔗 Related Articles
- Blue Bird Bids autobidding bot mystery deepens…
- ZiNRAi Review: Jason Brown’s Iyovia spinoff
- Auvoria Prime Review: Eaconomy securities fraud reboot
- FTC’s Success By Health lawsuit survives motion to dismiss
- Investview lies about iGenius trading bot in new compliance docs